Philippe Bedard

Philippe Bedard, MD, FRCPC

Follow Dr. Bedard:
Dr. Bedard received his medical degree from the University of Toronto where he was awarded the Cody Academic Silver Medal. He completed his Internal Medicine and Medical Oncology specialty training at the University of Toronto. He received additional fellowship training in clinical and translational breast cancer research at the Breast International Group (BIG).
 
In recognition of his research excellence, Dr. Bedard received the 2012 Career Development Award from the the Conquer Cancer Foundation of the American Society of Clinical Oncology.
Dr. Bedard has a clinical practice and a research program. His clinical practice includes the treatment of patients with breast and testicular cancers. His research program involves early phase clinical trials with novel cancer drug treatments. These emerging treatments include immunotherapy and the personalization of cancer treatment based upon the results of testing for DNA mutations within tumor cells.
 
As a member of the Steering Committee for the AACR-GENIE project, Dr. Bedard is contributing to this international data-sharing initiative, which links cancer genomic data with clinical outcomes from tens of thousands of cancer patients treated at leading international institutions.
Breast Cancer Res Treat. 2017 Nov 24;:
Pezo RC, Chen TW, Berman HK, Mulligan AM, Razak AA, Siu LL, Cescon DW, Amir E, Elser C, Warr DG, Sridhar SS, Yu C, Wang L, Stockley TL, Kamel-Reid S, Bedard PL
Clin Colorectal Cancer. 2017 Oct 23;:
Chiu JW, Krzyzanowska MK, Serra S, Knox JJ, Dhani NC, Mackay H, Hedley D, Moore M, Liu G, Burkes RL, Brezden-Masley C, Roehrl MH, Craddock KJ, Tsao MS, Zhang T, Yu C, Kamel-Reid S, Siu LL, Bedard PL, Chen EX
Curr Oncol. 2017 Oct;24(5):e403-e422
Chang MC, Souter LH, Kamel-Reid S, Rutherford M, Bedard P, Trudeau M, Hart J, Eisen A, Molecular Oncology Advisory Committee
Clin Cancer Res. 2017 Oct 24;:
Banerji U, Dean E, Pérez-Fidalgo JA, Batist G, Bedard PL, You B, Westin SN, Kabos P, Garrett MD, Tall M, Ambrose HJ, Barrett JC, Carr TH, Cheung SA, Corcoran C, Cullberg M, Davies BR, de Bruin EC, Elvin P, Foxley A, Lawrence P, Lindemann JPO, Maudsley...
Cancer. 2017 Oct 04;:
Bédard PL, Davies MA, Kopetz S, Juric D, Shapiro GI, Luke JJ, Spreafico A, Wu B, Castell C, Gomez C, Cartot-Cotton S, Mazuir F, Dubar M, Micallef S, Demers B, Flaherty KT
Clin Genitourin Cancer. 2017 Sep 04;:
Kwan EM, Beck S, Amir E, Jewett MA, Sturgeon JF, Anson-Cartwright L, Chung PW, Warde PR, Moore MJ, Bedard PL, Tran B
Invest New Drugs. 2017 Sep 14;:
Shepshelovich D, Goldvaser H, Wang L, Abdul Razak AR, Bedard PL
BMC Cancer. 2017 Sep 12;17(1):646
Reynolds KL, Bedard PL, Lee SH, Lin CC, Tabernero J, Alsina M, Cohen E, Baselga J, Blumenschein G, Graham DM, Garrido-Laguna I, Juric D, Sharma S, Salgia R, Seroutou A, Tian X, Fernandez R, Morozov A, Sheng Q, Ramkumar T, Zubel A, Bang YJ
Clin Genitourin Cancer. 2017 Aug 31;:
Barua R, Magony A, Khalili K, Bedard PL, Hansen AR, Lewin J

Pages


 

Associate Professor, Faculty of Medicine, University of Toronto
Member, Steering Committee, American Association for Cancer Research (AACR) Genomics, Evidence, Neoplasia, Information, Exchange (GENIE) Project
Staff Medical Oncologist, Division of Medical Oncology, Princess Margaret Cancer Centre
Fellowship Director, Bras Drug Development Program, Princess Margaret Cancer Centre
Clinical Director, Cancer Genomics Program, Princess Margaret Cancer Centre